Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01392209
Title Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

high grade glioma

malignant astrocytoma

oligodendroglioma

mixed glioma

Therapies

Bevacizumab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Francisco San Francisco California 94143 United States Details
Memorial Sloan Kettering Basking Ridge Basking Ridge New Jersey 07920 United States Details
Memorial Sloan Kettering Commack Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field